On 18 February 2020, OEL (Holdings) Limited restructured its wholly owned subsidiary, AJJ HEALTH CARE MANAGEMENT PTE. LTD (AJJH). On April 1, 2020, OEL held a general meeting to approve the diversifying the group's core businesses, including investments in the healthcare sector, AJJH was successful on 21 April 2020 acquisition of the first China-based healthcare company: the Shanghai Longjian Hospital Management Co.,Ltd.
Registered on March 7, 2019 in Shanghai, China, Shanghai Longjian is a healthcare organization engaged in the operation, medical investment consulting and health service management. The company's legal representative, Dr. Ye Wenzheng, is one of the most authoritative representatives of hematology in China and has made three "first discoveries" in the field of medical research in China. In addition, the company has a number of top medical experts, including Tang Guomin, Wang Zhifang and Jiang Wei. Dr. Ye Wenzheng will continue to lead the acquired Longjian, expanding specialty hospital care and geriatric care management, medical devices and pharmaceuticals consumer industry business.
With the COVID-19 epidemic sweeping the world, there is an urgent need to supply highly effective medical equipment. The acquired Longjian is targeting this need by using hydrogen oxygen nebulization medical technology to serve frontline hospitals in China that are treating the outbreak. This technology is currently being used as an adjunctive treatment for novel coronavirus pneumonia at the COVID-19 specialist hospital. At the same time, OEL plans to expand the use of this medical oxygen hydrogen nebulization technology into Southeast Asia and other countries with severe outbreaks. OEL and the acquired Longjian are also advancing the HIFU (High Intensity Focused Ultrasonic Floating Unit) specifically for oncology treatment, supply of medical services and other elderly care hospital projects.
